Company Name
Crystalplex

Web Site
www.crystalplex.com

Description of Company Mission
Crystalplex develops and commercializes innovative fluorescent markers for use in biological research and testing. The technology is based on proprietary composition-tunable nanocrystals (quantum dots).  Crystalplex products promise to reduce the labor and shorten the time required for academic and pharmaceutical research.  Applications in the optoelectronics segment represent a significant part of the company’s value going forward.   

Industry
Biotech Tools

Stage of Commercialization
Early Stage

Market Size
$1B

PLSG Funding to Date
$325,000

CEO Name
Matthew Bootman

PLSG Executive in Residence
H. Safferstein

Number of Employees
4

Location
Pittsburgh, PA